PATENT CLAIM ANALYSIS

Application Number: 16315263
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "275000"]

Abstract:
Provided is a pharmaceutical composition for preventing and treating tumors, the pharmaceutical composition including an imidazooxazole derivative compound, a solvate, a stereoisomer, or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition is administered to an entity which has developed a tumor or is in danger of developing a tumor, and thus tumors can be prevented or treated.

Claim (Index 7):
The pharmaceutical composition of  claim 6 , wherein the compound or the solvate, stereoisomer, or pharmaceutically acceptable salt thereof inhibits protein kinase to inhibit proliferation of tumor cells.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 99.0
- Lexical Diversity: 1.51111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12274834', '14436145', '15841902', '13509442', '13506510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7817496792104981
- 35 USC 102 Novelty (BERT): 0.5429552456037188
- Combined Prediction Score: 0.7578702358498202
- Mean Citation Score: 333.91248600000006
- Max Citation Score: 374.03793
- Similarity Product: 178.0307220808116

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test